TARDBP and amyotrophic lateral sclerosis: It is debated whether aggregation of TDP-43 in the cytoplasm of ALS and FTLD-U patients causes neurodegeneration due to formation of toxic protein aggregates (gain of function) or to the translocation of TDP-43 from the nucleus, which represents its physiological location, to the cytoplasm (loss of function), or both.